Directed walk designs for dose-response problems with competing failure modes
DOI10.1111/1541-0420.00029zbMATH Open1210.62166OpenAlexW2123634739WikidataQ52010745 ScholiaQ52010745MaRDI QIDQ3079102FDOQ3079102
Authors: Mary C. Meyer, Q. F. Stout, Janis P. Hardwick 
Publication date: 1 March 2011
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://hdl.handle.net/2027.42/66162
Recommendations
random walkBayesianexperimental designefficiencynonparametricCRMsequentialunimodalisotonicconvex-concavephase I/II
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Optimal statistical designs (62K05)
Cites Work
- Dose-finding designs for HIV studies
- A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Group Sequential Tests for Bivariate Response: Interim Analyses of Clinical Trials with Both Efficacy and Safety Endpoints
- Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials
- Predictive Variable Selection in Generalized Linear Models
- Designs for Phase II Trials Allowing for a Trade-Off between Response and Toxicity
- A comparison of nonparametric shape constrained bioassey estimators
Cited In (5)
- Adaptive designs for dose-finding based on efficacy-toxicity response
- Optimizing a unimodal response function for binary variables
- Combined criteria for dose optimisation in early phase clinical trials
- Weighted \(L_{\infty}\) isotonic regression
- Up-and-Down Designs for Selecting the Dose with Maximum Success Probability
This page was built for publication: Directed walk designs for dose-response problems with competing failure modes
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3079102)
